Multiple Versus Single Dose of Ivermectin for the Treatment of Strongyloidiasis
Status:
Completed
Trial end date:
2018-06-08
Target enrollment:
Participant gender:
Summary
Ivermectin is currently the best drug to cure strongyloidiasis, but the "standard" single
dose of 200 mcg/kg is probably not enough to guarantee cure. As strongyloidiasis can be fatal
in immunosuppressed patients, it is mandatory to define the optimal dosage to eradicate the
parasite.
Aim of this study is to define the most effective dose schedule of ivermectin to cure
strongyloidiasis.